• Nie Znaleziono Wyników

Index of /rozprawy2/11083

N/A
N/A
Protected

Academic year: 2021

Share "Index of /rozprawy2/11083"

Copied!
2
0
0

Pełen tekst

(1)

1

List of contents

Abstract ... 3 List of abbreviations ... 5 1. Introduction ... 7 1.1. Cancer ... 7 1.2. Biomarkers ... 9 1.3. Breast cancer ... 10

1.3.1. Breast cancer characteristics ... 11

1.3.2. Breast cancer biomarkers ... 14

1.4. Prostate cancer... 16

1.4.1. Prostate cancer characteristics ... 17

1.4.2. Biomarkers in prostate cancer ... 19

1.5. Aptamers ... 20

1.5.1. General information on aptamers ... 20

1.5.2. SELEX... 21

1.5.3. Aptamers as drugs ... 24

1.6. Cancer models ... 29

1.6.1. Orthotopic cancer models ... 29

1.6.2. Breast cancer cell lines – MCF7 ... 30

1.6.3. Prostate cancer cell line – PC3 ... 31

1.7. Proteomics as a branch of life sciences ... 32

2. Aims of the study ... 34

3. Materials and methods ... 35

3.1. Polyacrylamide gel separation - SDS-PAGE ... 37

3.2. Sample preparation protocol ... 38

3.3. nanoLC-MS/MS analysis ... 39

3.4. Bioinformatic tools ... 41

3.5. Proteome analysis of orthotopic breast cancer model ... 41

3.5.1. Qualitative analysis (orthotopic breast cancer model)... 42

3.5.2. Quantitative analysis (orthotopic breast cancer model) ... 43

3.5.3. Western blotting (orthotopic breast cancer model) ... 46

3.6. Comprehensive analysis of proteins targeted by aptamers possessing antitumor activity in cancer cell model PC3-luc. ... 47

3.6.1. Cell cultures ... 47

3.6.2. Aptamer binding assay ... 48

3.6.3. Optimization of aptamer's concentration ... 49

3.6.4. Homogenization method ... 50

3.6.5. Optimization of the aptamer-binding target enrichment process ... 52

(2)

2

4. Results ... 58

4.1. Proteomic analysis of the orthotopic breast cancer MCF7 model ... 58

4.1.1. Qualitative analysis (orthotopic breast cancer model)... 58

4.1.2. The results of quantitative analysis (orthotopic breast cancer model) ... 61

4.1.3. Western blotting (orthotopic breast cancer model) ... 67

4.2. Results of the analysis of the proteins targeted by aptamers ... 68

4.2.1. Optimization of the aptamers' concentration ... 68

4.2.2. Optimization of the homogenization method ... 70

4.2.3. Enrichment process of the aptamer binding targets ... 74

4.2.4. Aptamers labeled with fluorescent dye Atto-488 ... 85

5. Discussion ... 88

6. Final conclusions ... 96

Streszczenie ... 96

Bibliography ... 99

Cytaty

Powiązane dokumenty

In this study, gene expression in clear cell carcinoma of the kidney (RCC), normal kidney, and a set of diseased non-malignant kidneys, was examined.. RNA was prepared and gene

Klinika Onkologii, Centralny Szpital Kliniczny WAM, Warszawa.. Przeprowa- dzone badania udowodni³y wp³yw angiogennych substancji na wzrost guza. Uczeni przedstawili

Dworakowska 50 zwiêkszony odsetek komórek apoptotycznych zale¿noœæ pomiêdzy niskim WA a obecnoœci¹ bia³ka mdm2, i wsp.. [34] korelowa³ z gorszym rokowaniem

Jedynie grupa pacjentów z jednym zajêtym narz¹dem, z ECOG 0 oraz z histologicznie potwierdzonym rakiem ja- snokomórkowym nerki uzyska³a przed³u¿enie

Expression of apoptosis regulatory proteins of the bcl-2 family and p53 in primary resected non-small- -cell lung cancer.. Hockenbery D, Zutter M, Hickey

The aim of the study was to determine the in vitro effects of angiotensin peptides (Ang II, Ang III and Ang IV) on the secretion of VEGF in two anterior pituitary adenoma cell

The aim of our study was the immunohistoche- mical evaluation of p53, bcl-2 and nm23 expression in squamous cell lung cancers in relation to basic cli- nical and pathological

Introduction: The aim of the study was to assess quantitative acute phase protein (APP) level changes in patients with non- -small cell lung cancer (NSCLC) subjected to